Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Operating Expenses: 2019-2025

Historic Operating Expenses for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $9.8 million.

  • Benitec Biopharma's Operating Expenses rose 77.25% to $9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $41.8 million, marking a year-over-year increase of 85.70%. This contributed to the annual value of $41.8 million for FY2025, which is 85.70% up from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Operating Expenses is $9.8 million, which was down 35.87% from $15.3 million recorded in Q1 2025.
  • In the past 5 years, Benitec Biopharma's Operating Expenses registered a high of $15.3 million during Q1 2025, and its lowest value of $3.5 million during Q1 2022.
  • In the last 3 years, Benitec Biopharma's Operating Expenses had a median value of $5.8 million in 2023 and averaged $7.3 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first dropped by 7.54% in 2022, then surged by 270.32% in 2025.
  • Benitec Biopharma's Operating Expenses (Quarterly) stood at $4.9 million in 2021, then increased by 15.72% to $5.6 million in 2022, then climbed by 23.17% to $6.9 million in 2023, then surged by 55.98% to $10.8 million in 2024, then skyrocketed by 77.25% to $9.8 million in 2025.
  • Its Operating Expenses was $9.8 million in Q2 2025, compared to $15.3 million in Q1 2025 and $10.8 million in Q4 2024.